LOGO
LOGO

Breaking News

Dechra Pharma 6-month Underlying EPS Up - Quick Facts

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

Dechra Pharmaceuticals Plc's (DPH.L) six-month pre-tax profit decreased to 8.9 million pounds from 9.0 million pounds in the prior-year period. On a per share basis, half-yearly earnings improved to 10.06 pence from 10.05 pence a year ago.

Underlying pre-tax profit was 14.3 million pounds compared with 13.9 million pounds achieved in 2010. At constant currency and excluding foreign currency gains and losses, underlying pre-tax profit was £15.1 million, up 11.3% versus 2010. Underlying earnings per share were 15.82 pence, higher than last year's 15.51 pence.

Revenue for the six months ended December 31, 2011 totaled 209.5 million pounds, up 9.0% from 192.2 million pounds in the previous year.

The board also declared an interim dividend of 4.1 pence per share, an increase of 10.8%, payable on 10 April 2012 to Shareholders on the Register of Members at close of business on 9 March 2012. The ordinary shares would become ex dividend on 7 March 2012.

For comments and feedback contact: editorial@rttnews.com

Business News

Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.

Latest Updates on COVID-19